Browsed by
Tag: Trial

Health economic evaluation of a randomized controlled trial (EMBLA study), an internet-based treatment for provoked vulvodynia
Health economic evaluation of a randomized controlled trial (EMBLA study), an internet-based treatment for provoked vulvodynia

Health economic evaluation of a randomized controlled trial (EMBLA study), an internet-based treatment for provoked vulvodynia

Design This overall health financial analysis has a health care company point of view and is based on information from the EMBLA study, a multicenter randomized analyze that investigated the results of a 6-7 days guided world-wide-web intervention for provoked vulvodynia21. The analyze was accepted by the Ethical Regional Board in Uppsala, Sweden (registration numbers 2015/031 and 2020–07,179), and registered at clinicaltrials.gov (protocol ID EMBLA, ID NCT02809612, 22/06/2016). All experiments ended up done in accordance with the Declaration of Helsinki…

Read More Read More

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Summary Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. We aimed to establish whether the addition of molnupiravir to usual care reduced hospital admissions and deaths associated with COVID-19 in this population. Methods PANORAMIC was a UK-based, national, multicentre, open-label, multigroup, prospective, platform adaptive randomised controlled trial. Eligible participants were aged 50 years or older—or…

Read More Read More

A digital application and augmented physician rounds reduce postoperative pain and opioid consumption after primary total knee replacement (TKR): a randomized clinical trial | BMC Medicine
A digital application and augmented physician rounds reduce postoperative pain and opioid consumption after primary total knee replacement (TKR): a randomized clinical trial | BMC Medicine

A digital application and augmented physician rounds reduce postoperative pain and opioid consumption after primary total knee replacement (TKR): a randomized clinical trial | BMC Medicine

Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–76. Article  PubMed  Google Scholar  Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis. BMJ. 2017;359:j4792. Article  PubMed  Google Scholar  Hirschfeld DJ. Trump Declares Opioid Crisis a ‘Health Emergency’ Requests no Funds The New York Times; 2017. Google Scholar  Hollmann MW, Rathmell JP, Lirk P….

Read More Read More

Comparative Oncology: Trial cancer treatments for dogs could also lead to breakthroughs for humans – 60 Minutes
Comparative Oncology: Trial cancer treatments for dogs could also lead to breakthroughs for humans – 60 Minutes

Comparative Oncology: Trial cancer treatments for dogs could also lead to breakthroughs for humans – 60 Minutes

If you’ve ever lost a dog to disease. It may well have been cancer. Some 4 million dogs in the U.S. are diagnosed with it every year, often the same kinds of cancers humans get.  We share many of the same genes with our canine companions. And for cancer research, that’s an opportunity scientists are trying to make the most of. It’s called comparative oncology. Now funded in part by the White House’s Cancer Moonshot Initiative, doctors and scientists are…

Read More Read More

First human trial goes well
First human trial goes well

First human trial goes well

Share on PinterestIn a tiny trial, researchers have applied gene-editing technology for the very first time to deal with breast, colon, and lung most cancers in people. Impression credit score: Andrew Brookes/Getty Photographs. For the first time, scientists have utilised CRISPR technological innovation to substitute genes in patients’ immune cells to take care of most cancers. Individuals incorporated 16 individuals with various strong cancers together with breast, colon, and lung cancers. Researchers isolated and cloned T-cell receptors from the patient’s…

Read More Read More

MGH recruiting for trial of new treatment for vaping addiction
MGH recruiting for trial of new treatment for vaping addiction

MGH recruiting for trial of new treatment for vaping addiction

Michael Werner was a university university student in Vermont when he to start with made use of an digital cigarette.”I anticipated it to be hard to quit working with,” he explained. “I will not assume I envisioned it to be pretty as tough as it in the end was.”Slender and discreet, the vaping system from Juul reworked the tobacco market when it was initially introduced in 2015.”You can use them in bogs,” Werner explained. “You can use them in the…

Read More Read More